Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Viral Transfer Technology
  • Published:

High throughput production, screening and analysis of adeno-associated viral vectors

Abstract

Recombinant adeno-associated viruses (rAAV) are promising candidates as gene vectors, as they transduce non-dividing cells and permit lasting transgene expression in a wide spectrum of tissues. In this paper, we describe a robust procedure for the high throughput production, screening and characterization of rAAV vectors. The technology includes the production of rAAV from rapid small scale plasmid preparations and the analysis of virus productivity (physical and infectious particles) and activity (transgene expression, replication). rAAV are produced by triple transfection (rAAV plasmid and AAV- and adenovirus (Ad)-helper plasmids) on 293 human embryo kidney (HEK) cells. The titers of physical and infectious particles are obtained by dot blot hybridization and by a serial dilution assay, followed by either dot blot hybridization or real-time PCR, respectively. rAAV can be produced and characterized from plasmid mixtures containing as little as 1/100 productive molecules. Experiments on rAAV replication kinetics and Ad helper functions are discussed. All steps are performed in 96-well microtiter plates. The process is reproducible, high throughput, linear and ready for automation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  1. Mulligan RC . The basic science of gene therapy Science 1993 260: 926–932

    Article  CAS  PubMed  Google Scholar 

  2. Verma IM, Somia N . Gene therapy – promise, problems and prospects Nature 1997 389: 239–242

    Article  CAS  PubMed  Google Scholar 

  3. Atkinson EM, Debelak DJ, Hart LA, Reynolds TC . A high-throughput hybridisation method for titer determination of viruses and gene therapy vectors Nucleic Acids Res 1998 26: 2821–2823

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Vidal M, Endoh H . Prospects for drug screening using the reverse two-hybrid system Trends Biotechnol 1999 17: 374–380

    Article  CAS  PubMed  Google Scholar 

  5. Sykes KF, Johnston SA . Linear expression elements: a rapid in vivo, methods to screen for gene functions Nat Biotechnol 1999 17: 355–359

    Article  CAS  PubMed  Google Scholar 

  6. Mahairas GG et al. Sequence-tagged connectors: a sequence approach to mapping and scanning the human genome Proc Natl Acad Sci USA 1999 96: 9739–9744

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Hanzel DK, Trojanowski JQ, Johnston RF, Loring JF . High-throughput quantitative histological analysis of Alzheimer's disease pathology using a confocal digital microscanner Nat Biotechnol 1999 17: 53–57

    Article  CAS  PubMed  Google Scholar 

  8. Mazumder A, Majlessi M, Becker MM . A high throughput method to investigate oligodeoxyribonucleotide hybridization kinetics and thermodynamics Nucleic Acids Res 1998 26: 1996–2000

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Davis AR, Meyers K, Wilson JM . High throughput method for creating and screening recombinant adenoviruses Gene Therapy 1998 5: 1148–1152

    Article  CAS  PubMed  Google Scholar 

  10. Hallek M et al. Recombinant adeno-associated virus vectors Curr Res Mol Ther 1998 1: 417–430

    CAS  Google Scholar 

  11. Flotte TR, Carter BJ . Adeno-associated virus vectors for gene therapy Gene Therapy 1995 2: 357–362

    CAS  PubMed  Google Scholar 

  12. Herzog RW et al. Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus Proc Natl Acad Sci USA 1997 94: 5804–5809

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Snyder RO et al. Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompeted mice Hum Gene Ther 1997 8: 1891–1900

    Article  CAS  PubMed  Google Scholar 

  14. Goodman S et al. Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells Blood 1994 84: 1492–1500

    CAS  PubMed  Google Scholar 

  15. Bartlett JS, Samulski RJ, McCown TJ . Selective and rapid uptake of adeno-associated virus type 2 in brain Hum Gene Ther 1998 9: 1181–1186

    Article  CAS  PubMed  Google Scholar 

  16. Bennett J et al. Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina Proc Natl Acad Sci USA 1999 96: 9920–9925

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Dudus L et al. Persistent transgene product in retina, optic nerve and brain after intraocular injection of rAAV Vision Res 1999 39: 2545–2553

    Article  CAS  PubMed  Google Scholar 

  18. Snyder RO et al. Correction of hemophilia B in canine and murine models using recombinant adeno-associated-virus vectors Nature Med 1999 5: 64–70

    Article  CAS  PubMed  Google Scholar 

  19. Salvetti A et al. Factors influencing recombinant adeno-associated virus production Hum Gene Ther 1998 9: 695–706

    Article  CAS  PubMed  Google Scholar 

  20. Snyder RO, Xiao X, Samulski RJ . Production of recombinant adeno-associated viral vectors. In: Dracopoli N et al (eds) Current Protocols in Human Genetics John Wiley and Sons: New York 1996 12.1.1–12.1.24

    Google Scholar 

  21. Heid CA, Stevens J, Livak KJ et al. Real-time quantitative PCR Genome Res 1996 6: 986–994

    Article  CAS  PubMed  Google Scholar 

  22. Qing K et al. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2 Nature Med 1999 5: 71–77

    Article  CAS  PubMed  Google Scholar 

  23. Li J, Samulski RJ, Xiao X . Role for highly regulated rep gene expression in adeno-associated virus vector production J Virol 1997 71: 5236–5243

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Xiao X, Li J, Samulski RJ . Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus J Virol 1998 72: 2224–2232

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank Karin Jooss, Eric Kremer, Philippe Moullier and Nestor Soria for critically reading of the manuscript; Nasser Armande and Pascal Martinez for the computer program developed for the tangential hyperbole-based analysis; and for kindly providing mini-prep rAAV-lacZ plasmid (Pascale Bouille) Ad2, Ad5, ts-Ad adenoviruses, rep+/cap+ HeLa cells and pAAV-lacZ (Philippe Moullier and Anna Salvetti), CAV-1 and CAV-2 (Eric Kremer) and pAB11, pACG.2 and pXX6 plasmids (R Jude Samulsky).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Drittanti, L., Rivet, C., Manceau, P. et al. High throughput production, screening and analysis of adeno-associated viral vectors. Gene Ther 7, 924–929 (2000). https://doi.org/10.1038/sj.gt.3301191

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301191

Keywords

This article is cited by

Search

Quick links